SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/04/15 Revance Therapeutics, Inc. 10-K 12/31/14 101:15M Workiva Inc Wde… FA01/FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 1.45M 2: EX-10.25 Material Contract HTML 35K 3: EX-10.40 Material Contract HTML 63K 4: EX-10.42 Material Contract HTML 206K 5: EX-23.1 Consent of Experts or Counsel HTML 29K 6: EX-31.1 Certification -- §302 - SOA'02 HTML 35K 7: EX-31.2 Certification -- §302 - SOA'02 HTML 35K 8: EX-32.1 Certification -- §906 - SOA'02 HTML 32K 9: EX-32.2 Certification -- §906 - SOA'02 HTML 32K 70: R1 Document and Entity Information HTML 59K 56: R2 Consolidated Balance Sheets HTML 140K 68: R3 Consolidated Balance Sheets (Parenthetical) HTML 63K 73: R4 Consolidated Statement of Operations and HTML 109K Comprehensive Loss 92: R5 Consolidated Statements of Changes in Convertible HTML 256K Preferred Stock and of Stockholders’ Equity (Deficit) 59: R6 Consolidated Statements of Changes in Convertible HTML 41K Preferred Stock and of Stockholders’ Equity (Deficit) (Parenthetical) 67: R7 Consolidated Statements of Cash Flows HTML 234K 51: R8 The Company and Basis of Presentation HTML 44K 41: R9 Summary of Significant Accounting Policies HTML 83K 93: R10 License Agreements HTML 37K 75: R11 Medicis Settlement HTML 43K 74: R12 Fair Value Measurements HTML 123K 80: R13 Balance Sheet Components HTML 82K 81: R14 Notes Payable HTML 60K 78: R15 Convertible Notes, Warrants, and Related HTML 61K Derivatives 82: R16 Interest Expense HTML 62K 69: R17 Commitments and Contingencies HTML 47K 71: R18 Common Stock HTML 51K 77: R19 Convertible Preferred Stock HTML 62K 101: R20 Warrants HTML 64K 88: R21 Stock Option Plan HTML 232K 63: R22 Net Income (Loss) per Share Attributable to Common HTML 80K Stockholders 76: R23 Income Taxes HTML 93K 65: R24 Defined Contribution Plan HTML 34K 32: R25 Subsequent Events HTML 37K 89: R26 Quarterly Results of Operations (Unaudited) HTML 86K 97: R27 Summary of Significant Accounting Policies HTML 147K (Policies) 46: R28 Fair Value Measurements (Tables) HTML 117K 45: R29 Balance Sheet Components (Tables) HTML 85K 49: R30 Notes Payable (Tables) HTML 42K 50: R31 Convertible Notes, Warrants, and Related HTML 41K Derivatives (Tables) 52: R32 Interest Expense (Tables) HTML 60K 24: R33 Commitments and Contingencies (Tables) HTML 37K 86: R34 Common Stock (Tables) HTML 48K 61: R35 Convertible Preferred Stock (Tables) HTML 52K 64: R36 Warrants (Tables) HTML 52K 36: R37 Stock Option Plan (Tables) HTML 210K 100: R38 Net Income (Loss) per Share Attributable to Common HTML 81K Stockholders (Tables) 16: R39 Income Taxes (Tables) HTML 83K 53: R40 Quarterly Results of Operations (Unaudited) HTML 85K (Tables) 91: R41 The Company and Basis of Presentation - Additional HTML 90K Information (Detail) 34: R42 Summary of Significant Accounting Policies HTML 71K (Details) 44: R43 License Agreements (Details) HTML 52K 48: R44 Medicis Settlement - Additional Information HTML 79K (Detail) 57: R45 Fair Value Measurements - Schedule of Fair Value HTML 89K of Financial Instruments (Detail) 23: R46 Fair Value Measurements - Summary of Changes in HTML 95K Fair Value of Financial Instruments (Detail) 40: R47 Fair Value Measurements (Narrative) (Details) HTML 31K 18: R48 Balance Sheet Components - Additional Information HTML 38K (Detail) 90: R49 Balance Sheet Components - Schedule of Property HTML 55K and Equipment, Net (Detail) 33: R50 Balance Sheet Components - Schedule of Prepaid HTML 42K Expenses and Other Current Assets (Detail) 87: R51 Balance Sheet Components - Schedule of Accruals HTML 57K and Other Current Liabilities (Detail) 37: R52 Balance Sheet Components - Schedule of Other HTML 40K Non-Current Assets (Detail) 54: R53 Notes Payable - Hercules Notes Payable (Detail) HTML 97K 17: R54 Notes Payable - Essex Capital Notes (Detail) HTML 111K 21: R55 Notes Payable - Summary of Aggregate Total Future HTML 37K Minimum Lease Payments under the Financing Obligation (Detail) 47: R56 Notes Payable - Summary of Future Principal HTML 44K Payments under the Notes Payable (Detail) 27: R57 Convertible Notes, Warrants, and Related HTML 154K Derivatives - Additional Information (Detail) 94: R58 Convertible Notes, Warrants, and Related HTML 46K Derivatives - Fair Value Assumptions Using "Monte Carle" Simulation (Details) 60: R59 Interest Expense - Summary of Interest Expense by HTML 56K Cash and Non-Cash Components (Detail) 79: R60 Commitments and Contingencies - Additional HTML 44K Information (Detail) 39: R61 Commitments and Contingencies - Schedule of Future HTML 48K Minimum Lease Payments under Non-Cancelable Operating Leases (Detail) 42: R62 Common Stock - Additional Information (Detail) HTML 61K 85: R63 Convertible Preferred Stock - Additional HTML 137K Information (Detail) 83: R64 Convertible Preferred Stock - Outstanding HTML 80K (Details) 62: R65 Warrants - Additional Information (Detail) HTML 151K 84: R66 Warrants - Schedule of Warrants (Details) HTML 55K 38: R67 Warrants - Assumptions Using Black-Scholes Model HTML 39K (Details) 66: R68 Stock Option Plan - Additional Information HTML 140K (Detail) 96: R69 Stock Option Plan - Summary of Stock Option and HTML 175K Restricted Stock Award Activity (Details) 20: R70 Stock Option Plan - Stock Options Outstanding and HTML 89K Exercisable (Details) 31: R71 Stock Option Plan - Summary of Restricted Stock HTML 64K Award Activity (Details) 55: R72 Stock Option Plan - Fair Value Assumptions HTML 59K (Details) 26: R73 Stock Option Plan - Schedule of Stock-based HTML 41K Compensation Expense (Details) 99: R74 Net Income (Loss) per Share Attributable to Common HTML 104K Stockholders - Schedule of Computation of Basic and Diluted Net Income (Loss) Per Share Attributable to Common Stockholders (Detail) 35: R75 Net Income (Loss) per Share Attributable to Common HTML 50K Stockholders - Summary of Common Stock Equivalents Excluded from Computation of Diluted Net Income (Loss) Per Share (Detail) 28: R76 Income Taxes - Additional Information (Detail) HTML 61K 30: R77 Income Taxes - Deferred Tax Assets and Liabilities HTML 61K (Details) 22: R78 Income Taxes - Effective Tax Rate Reconciliation HTML 58K (Details) 25: R79 Income Taxes - Unrecognized Tax Benefits (Details) HTML 40K 72: R80 Defined Contribution Plan - Additional Information HTML 31K (Details) 29: R81 Subsequent Events - Additional Information HTML 82K (Details) 95: R82 Quarterly Results of Operations (Unaudited) - HTML 67K Additional Information (Details) 98: XML IDEA XML File -- Filing Summary XML 166K 19: EXCEL IDEA Workbook of Financial Reports XLSX 270K 43: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 2.07M 10: EX-101.INS XBRL Instance -- rvnc-20141231 XML 3.11M 12: EX-101.CAL XBRL Calculations -- rvnc-20141231_cal XML 254K 13: EX-101.DEF XBRL Definitions -- rvnc-20141231_def XML 895K 14: EX-101.LAB XBRL Labels -- rvnc-20141231_lab XML 2.31M 15: EX-101.PRE XBRL Presentations -- rvnc-20141231_pre XML 1.37M 11: EX-101.SCH XBRL Schema -- rvnc-20141231 XSD 250K 58: ZIP XBRL Zipped Folder -- 0001628280-15-001461-xbrl Zip 322K
Download this zipped .zip folder | |
Files: | rvnc-20141231.xml rvnc-20141231_cal.xml rvnc-20141231_def.xml rvnc-20141231_lab.xml rvnc-20141231_pre.xml rvnc-20141231.xsd |